An observational study in Heart Disease, sponsored by Piedmont Healthcare. Withdrawn. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-09-05.
Sponsored by Piedmont Healthcare · Observational
This study will use excess tissue from endoscopic or surgical procedures to examine the elements of plaque that are found in the carotid walls of patients who have a type of heart and blood vessel disease called atherosclerosis. Tissue will be collected from patients undergoing carotid procedures as well as patients undergoing liver and/or intestinal biopsies. This lab study will examine the different types of proteins that play a role in developing heart plaque.
3,639 studies on the registry are indexed under Heart Diseases; 461 are open to participants now.
Browse Heart Diseases studies →Piedmont Healthcare is the lead sponsor of 17 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients undergoing a carotid, liver, and/or intestinal biopsy
Exclusion Criteria:
Demonstrated Plaques
Presence of both liver and intestinally derived lipoprotein particles demonstrated in human atherosclerotic plaques.
Time frame: up to 30 months
No study locations are listed for this record.
This study is withdrawn, as verified in Jul 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Piedmont Healthcare